Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

416
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
416
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

661
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
661
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

337
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
337
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

3.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

245
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
245
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

343
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
343

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise training for cardiovascular prevention in patients with cancer.

European heart journal·2026
Same author

Evaluation of neutrophil oxidative burst capacity in relation to major adverse cardiac events and infection in patients with cardiovascular disease.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Safety of multiple grasping attempts during transcatheter mitral valve repair with the PASCAL system.

International journal of cardiology·2026
Same author

Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse events.

Cardio-oncology (London, England)·2026
Same author

Reverse engineering of BNIP3 identifies a mitochondrial protective peptide.

Nature communications·2026
Same author

Refining the treatment of immune checkpoint inhibitor-associated myocarditis: Challenges, innovations and rechallenge considerations.

British journal of pharmacology·2026

Related Experiment Video

Updated: Dec 24, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.3K

Cardiovascular Damage Associated With Chest Irradiation.

Simone M Mrotzek1, Tienush Rassaf1, Matthias Totzeck1

  • 1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, Medical Faculty, University Hospital Essen, Essen, Germany.

Frontiers in Cardiovascular Medicine
|April 9, 2020
PubMed
Summary

Long-term cancer survivors face increasing risks of heart damage after radiotherapy. This review details radiation-induced heart failure, its causes, and management strategies for better patient outcomes.

Keywords:
cancer therapycardio-oncologycardiotoxicitycardiovascular damageirradiationradiation therapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
07:08

Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis

Published on: August 31, 2022

1.9K

Related Experiment Videos

Last Updated: Dec 24, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
07:08

Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis

Published on: August 31, 2022

1.9K

Area of Science:

  • Cardiology
  • Oncology
  • Radiation Oncology

Background:

  • Improved cancer therapies lead to more long-term survivors after radiotherapy.
  • Cardiotoxicity following chest irradiation is a significant concern, often diagnosed late.
  • Radiation-induced heart failure with preserved ejection fraction is a poorly understood complication.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms of radiation-induced cardiovascular damage.
  • To characterize the development of cardiac side effects after radiotherapy.
  • To present clinical management and treatment options for radiation-induced heart conditions.

Main Methods:

  • Review of experimental and clinical data on radiation-induced cardiotoxicity.
  • Analysis of factors contributing to cardiovascular adverse events.
  • Synthesis of current understanding of heart failure with preserved ejection fraction post-radiation.

Main Results:

  • Cardiotoxicity is a major concern for radiotherapy survivors.
  • Heart radiation dose and cardiovascular risk factors influence the incidence and severity of cardiac damage.
  • Heart failure with preserved ejection fraction is a key manifestation of radiation-induced cardiotoxicity.

Conclusions:

  • Understanding radiation-induced heart damage is crucial for managing long-term cancer survivors.
  • Further research into heart failure with preserved ejection fraction is needed.
  • Clinical strategies for prevention and treatment are essential to mitigate cardiovascular risks.